Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. 08:08:04 09/12/2024 GMT 5-day change 1st Jan Change
11.58 HKD +3.02% Intraday chart for Genscript Biotech Corporation +7.42% -41.69%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Genscript Biotech's Rotating CEO Steps Down 12-02 MT
Shanghai Xuanren Technology Co., Ltd. announced that it has received funding from Huatai Zijin Investment Co. Ltd, Genscript Biotech Corporation, Shunwei, Inc. 12-01 CI
Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies 11-15 MT
Genscript Biotech Corporation Appoints Aylin Kosova Bilgin Has Joined as the First-Ever Chief Marketing Officer for GenScript Life Science Group 11-13 CI
Genscript Bio Associate Legend Biotech's Loss Doubles in Q3 11-13 MT
Genscript Biotech Unit Logs $286 Million in Sales from Carvykti in July-September 10-16 MT
Genscript Biotech Corporation Announces Late-Breaking Long-Term Overall Survival Data from Cartitude-4 Study in Multiple Myeloma 09-29 CI
Genscript Biotech Corporation Announces Board Appointments 09-12 CI
Genscript Biotech's H1 Loss Widens 08-12 MT
Genscript Biotech Corporation, H1 2024 Earnings Call, Aug 12, 2024 08-12
Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2024 08-09 CI
Genscript Biotech Corporation Appoints Peter Salovey to Its Board of Directors 08-09 CI
Genscript Biotech's US-Listed Unit Forecasts Up to $110 Million in January-June Loss 07-29 MT
Genscript Biotech Likely to Shrink Loss to Half in H1 07-29 MT
Genscript Biotech Corporation Provides Earnings Guidance for the Six Months Ended 30 June 2024 07-26 CI
Genscript Biotech Unit Logs $186 Million in Net Trade Sales from Carvykti in April-June 07-18 MT
Genscript Biotech to Use 68,054 RSA Shares for Scheme, Over 425 Million Shares Available Under General Mandate 07-10 MT
Genscript Biotech Grants Restricted Shares Under Incentive Scheme 07-09 MT
Genscript Biotech Corporation Announces Board and Committee Changes 07-05 CI
Genscript Biotech's Phase 3 Multiple Myeloma Drug Trial Yields Positive Results 07-04 MT
Genscript Biotech Units Receive Milestone Payment of $30 Million 06-28 MT
Genscript Biotech Corporation Announces Board Resignations and Changes in Composition of Board Committees 06-23 CI
GenScript Biotech Corporation Launches FLASH Gene Service: The Most Affordable Gene Synthesis Solution on the Market 06-18 CI
Genscript Biotech CEOs to Receive Shares Under Restricted Share Scheme 06-13 MT
Hong Kong Stocks Rebound Following More than Expected Growth in China’s Manufacturing Sector 06-03 MT
Chart Genscript Biotech Corporation
1548: Dynamic Chart
Logo Genscript Biotech Corporation
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.
Employees
7,284
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart GENSCRIPT-BIOTECH-CORPORAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1.490USD
Average target price
2.997USD
Spread / Average Target
+101.17%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1548 Stock
  4. News Genscript Biotech Corporation
  5. Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission